234 related articles for article (PubMed ID: 25582524)
1. Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.
Yuan W; Sanda M; Wu J; Koomen J; Goldman R
J Proteomics; 2015 Feb; 116():24-33. PubMed ID: 25582524
[TBL] [Abstract][Full Text] [Related]
2. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
[TBL] [Abstract][Full Text] [Related]
3. Optimized Fragmentation for Quantitative Analysis of Fucosylated N-Glycoproteins by LC-MS-MRM.
Yuan W; Wei R; Goldman R; Sanda M
Anal Chem; 2019 Jul; 91(14):9206-9212. PubMed ID: 31268672
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.
Ma J; Sanda M; Wei R; Zhang L; Goldman R
J Proteomics; 2018 Oct; 189():67-74. PubMed ID: 29427759
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Analysis of α-1-Antitrypsin Glycosylation Isoforms in HCC Patients Using LC-HCD-PRM-MS.
Yin H; Zhu J; Wang M; Yao ZP; Lubman DM
Anal Chem; 2020 Jun; 92(12):8201-8208. PubMed ID: 32426967
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation profiling of serum immunoglobulin in opisthorchiasis patients.
Onsurathum S; Kailemia MJ; Intuyod K; Haonon O; Pairojkul C; Thanan R; Pinlaor P; Lebrilla CB; Pinlaor S
J Proteomics; 2021 Jan; 230():103980. PubMed ID: 32927111
[TBL] [Abstract][Full Text] [Related]
7. Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.
Pompach P; Brnakova Z; Sanda M; Wu J; Edwards N; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1281-93. PubMed ID: 23389049
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Analysis of Sex-Hormone-Binding Globulin Glycosylation in Liver Diseases by Liquid Chromatography-Mass Spectrometry Parallel Reaction Monitoring.
Yuan W; Benicky J; Wei R; Goldman R; Sanda M
J Proteome Res; 2018 Aug; 17(8):2755-2766. PubMed ID: 29972295
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer.
Wieczorek M; Braicu EI; Oliveira-Ferrer L; Sehouli J; Blanchard V
Front Immunol; 2020; 11():654. PubMed ID: 32477323
[TBL] [Abstract][Full Text] [Related]
10. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
Mondal G; Saroha A; Bose PP; Chatterjee BP
Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry.
Ahn YH; Shin PM; Kim YS; Oh NR; Ji ES; Kim KH; Lee YJ; Kim SH; Yoo JS
Analyst; 2013 Nov; 138(21):6454-62. PubMed ID: 24027776
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
[TBL] [Abstract][Full Text] [Related]
13. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
[TBL] [Abstract][Full Text] [Related]
14. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.
Darebna P; Novak P; Kucera R; Topolcan O; Sanda M; Goldman R; Pompach P
J Proteomics; 2017 Feb; 153():44-52. PubMed ID: 27646713
[TBL] [Abstract][Full Text] [Related]
15. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
Zhang S; Jiang K; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
[TBL] [Abstract][Full Text] [Related]
18. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput Glycan Profiling of Human Serum IgG Subclasses Using Parallel Reaction Monitoring Peptide Bond Fragmentation of Glycopeptides and Microflow LC-MS.
Zhao Y; Raidas S; Mao Y; Li N
J Proteome Res; 2024 Feb; 23(2):585-595. PubMed ID: 38231888
[TBL] [Abstract][Full Text] [Related]
20. Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.
Zhu J; Chen Z; Zhang J; An M; Wu J; Yu Q; Skilton SJ; Bern M; Ilker Sen K; Li L; Lubman DM
J Proteome Res; 2019 Jan; 18(1):359-371. PubMed ID: 30370771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
